Sung Gwe Ahn

3.4k total citations
166 papers, 2.2k citations indexed

About

Sung Gwe Ahn is a scholar working on Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sung Gwe Ahn has authored 166 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Cancer Research, 84 papers in Oncology and 35 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sung Gwe Ahn's work include Breast Cancer Treatment Studies (71 papers), Breast Lesions and Carcinomas (30 papers) and HER2/EGFR in Cancer Research (23 papers). Sung Gwe Ahn is often cited by papers focused on Breast Cancer Treatment Studies (71 papers), Breast Lesions and Carcinomas (30 papers) and HER2/EGFR in Cancer Research (23 papers). Sung Gwe Ahn collaborates with scholars based in South Korea, United States and Japan. Sung Gwe Ahn's co-authors include Joon Jeong, Soong June Bae, Hak Min Lee, Yoon Jin, Chang Ik Yoon, Jung Hoon Yoon, Hy-De Lee, Seung Jun Kim, Do Kyung Kim and Chihwan Cha and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Sung Gwe Ahn

150 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sung Gwe Ahn South Korea 24 868 714 641 328 319 166 2.2k
Karl‐Heinz Thierauch Germany 19 908 1.0× 1.0k 1.4× 409 0.6× 502 1.5× 265 0.8× 33 2.5k
Tomislav Dragovich United States 24 1.1k 1.3× 1.0k 1.5× 444 0.7× 548 1.7× 270 0.8× 80 2.3k
Jeanine M.L. Roodhart Netherlands 22 1.3k 1.5× 1.0k 1.4× 646 1.0× 399 1.2× 175 0.5× 85 2.3k
Peter Shintaku United States 19 630 0.7× 1.0k 1.4× 553 0.9× 190 0.6× 253 0.8× 30 1.9k
Lisa M. Schumaker United States 24 702 0.8× 912 1.3× 346 0.5× 264 0.8× 481 1.5× 44 2.4k
Hiroaki Itamochi Japan 36 1.1k 1.3× 1.8k 2.6× 649 1.0× 313 1.0× 467 1.5× 139 3.6k
Cordula Petersen Germany 26 870 1.0× 1.0k 1.5× 493 0.8× 435 1.3× 165 0.5× 60 2.0k
Thomas Bachleitner‐Hofmann Austria 30 978 1.1× 1.3k 1.8× 1.1k 1.7× 300 0.9× 381 1.2× 86 2.7k
Sara Bravaccini Italy 27 922 1.1× 806 1.1× 659 1.0× 700 2.1× 215 0.7× 125 2.1k
Francis J. Giles United States 28 772 0.9× 1.0k 1.4× 345 0.5× 204 0.6× 255 0.8× 50 2.6k

Countries citing papers authored by Sung Gwe Ahn

Since Specialization
Citations

This map shows the geographic impact of Sung Gwe Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung Gwe Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung Gwe Ahn more than expected).

Fields of papers citing papers by Sung Gwe Ahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung Gwe Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung Gwe Ahn. The network helps show where Sung Gwe Ahn may publish in the future.

Co-authorship network of co-authors of Sung Gwe Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Sung Gwe Ahn. A scholar is included among the top collaborators of Sung Gwe Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung Gwe Ahn. Sung Gwe Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Minki, et al.. (2024). BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer. Cell Death Discovery. 10(1). 5–5. 7 indexed citations
2.
Kim, Jun Won, Ik Jae Lee, Joon Jeong, et al.. (2024). Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy. Yonsei Medical Journal. 65(3). 129–129. 3 indexed citations
3.
Ryu, Jai Min, Wonshik Han, Han‐Byoel Lee, et al.. (2024). Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Human Epidermal Growth Factor 2-Positive/Triple-Negative Breast Cancer Patients With Excellent Response. Journal of Breast Cancer. 27(2). 130–130. 3 indexed citations
4.
Lee, Miseon, Tae-Kyung Yoo, Byung Joo Chae, et al.. (2024). Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification. Scientific Reports. 14(1). 11278–11278. 3 indexed citations
5.
Hwang, Seung Hyun, Min Ji Lee, Yoonwon Kook, et al.. (2024). Clinical Relevance of TP53 Mutation and Its Characteristics in Breast Cancer with Long-Term Follow-Up Date. Cancers. 16(23). 3899–3899. 5 indexed citations
6.
Cho, Yeona, Jun Won Kim, Jee Suk Chang, et al.. (2023). Radiation dose-event relationship after intraoperative radiotherapy as a boost in patients with breast cancer. Frontiers in Oncology. 13. 1182820–1182820. 1 indexed citations
7.
Ahn, Sung Gwe, Soong June Bae, Jee Hung Kim, et al.. (2023). Comparison of Programmed Cell Death Ligand 1 Status between Core Needle Biopsy and Surgical Specimens of Triple-Negative Breast Cancer. Yonsei Medical Journal. 64(8). 518–518. 3 indexed citations
8.
Bae, Soong June, et al.. (2023). Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review. Journal of Breast Cancer. 26(4). 309–309. 4 indexed citations
9.
Bae, Soong June, Sung Gwe Ahn, Na Lae Eun, et al.. (2023). Resolution of Nonmass Enhancement Extension to the Nipple at Breast MRI after Neoadjuvant Chemotherapy: Pathologic Response and Feasibility for Nipple-sparing Mastectomy. Radiology. 307(2). e221777–e221777. 4 indexed citations
10.
11.
Ahn, Sung Gwe, Soong June Bae, Yoonjung Kim, et al.. (2022). Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR. npj Breast Cancer. 8(1). 58–58. 12 indexed citations
12.
Lee, Yong Joon, Jee Ye Kim, Seung Hyuck Jeon, et al.. (2022). CD39 + tissue-resident memory CD8 + T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer. Science Immunology. 7(74). eabn8390–eabn8390. 34 indexed citations
13.
Bae, Soong June, Sung Gwe Ahn, Dooreh Kim, et al.. (2022). Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy. Journal of Breast Cancer. 25(6). 485–485. 2 indexed citations
14.
Bae, Soong June, Kyung Soo Kim, Kyung‐A Lee, et al.. (2022). Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer. npj Breast Cancer. 8(1). 19–19. 11 indexed citations
15.
Kim, Jee Hung, et al.. (2022). SP142 PD-L1 Assays in Multiple Samples from the Same Patients with Early or Advanced Triple-Negative Breast Cancer. Cancers. 14(13). 3042–3042. 3 indexed citations
16.
Kim, Jee Ye, Soong June Bae, Yeona Cho, et al.. (2021). The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy. Cancers. 13(24). 6205–6205. 5 indexed citations
17.
Lee, Byung Min, Yeona Cho, Jun Won Kim, et al.. (2021). Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer. Cancers. 13(8). 1806–1806. 12 indexed citations
18.
Bae, Soong June, Yoon Jin, Na Lae Eun, et al.. (2021). Diagnostic Accuracy of Nonmass Enhancement at Breast MRI in Predicting Tumor Involvement of the Nipple: A Prospective Study in a Single Institution. Radiology. 301(1). 47–56. 6 indexed citations
19.
20.
Bae, Soong June, Chang Ik Yoon, Soeun Park, et al.. (2019). Immediate Breast Reconstruction Does Not Have a Clinically Significant Impact on Adjuvant Treatment Delay and Subsequent Survival Outcomes. Journal of Breast Cancer. 22(1). 109–109. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karl‐Heinz Thierauch Breakdown of academic impact, for papers by Tomislav Dragovich Breakdown of academic impact, for papers by Jeanine M.L. Roodhart Breakdown of academic impact, for papers by Peter Shintaku Breakdown of academic impact, for papers by Lisa M. Schumaker Breakdown of academic impact, for papers by Hiroaki Itamochi Breakdown of academic impact, for papers by Cordula Petersen Breakdown of academic impact, for papers by Thomas Bachleitner‐Hofmann Breakdown of academic impact, for papers by Sara Bravaccini Breakdown of academic impact, for papers by Francis J. Giles
Rankless by CCL
2026